The Rh(I) cyclopentadienyl olefin compounds [(η5-C5Me4R)Rh(olefin)2] (R = CMe3, SiMe3, SiMe2CMe3; olefin = C2H4, C2H3SiMe3) are readily prepared from the corresponding [RhCl(olefin)2]2 and zincocene, [Zn(C5Me4R)2], precursors. The new compounds undergo hydrogen/deuterium exchange at the olefinic sites in deuterated benzene, at a rate dependent on the cyclopentadienyl substituents.
No takes yet. Share an insight, caveat, or question.
Esqueda et al. (2008) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: